ABEC-L TABLET
| Product Name | ABEC-L Tablet |
| Active Ingredients | Abacavir + Lamivudine |
| Strength | As per standard formulation |
| Dosage Form | Tablet |
| Therapeutic Class | Antiretroviral |
| Indication | HIV Infection Management |
| Administration Route | Oral |
| Packaging | Blister/Bottle Pack |
| Storage | Store below 25Β°C in a cool, dry place |
| Shelf Life | As per the manufacturerβs label |
| Prescription | Required |
ABEC-L TABLET
ABEC-L Tablet is an effective antiretroviral medicine used in the management of HIV infection. It contains Abacavir and Lamivudine, a trusted combination that helps reduce viral load and supports immune system health. This tablet is commonly prescribed as part of combination antiretroviral therapy (ART) under medical supervision for improved treatment outcomes.
ABEC-L Tablet works by blocking reverse transcriptase enzymes that HIV needs to multiply in the body. By slowing viral replication, it helps maintain immune strength and reduces the risk of HIV-related complications. Consistent use as directed by a healthcare professional is essential to achieve maximum therapeutic benefit.
ABEC-L Tablet ensures safety, reliability, and consistent performance. It is widely supplied to hospitals, pharmacies, and global pharmaceutical buyers. Proper medical guidance and routine monitoring are recommended during therapy.
Product Features
- Contains Abacavir and Lamivudine combination
- Used in HIV combination therapy (ART)
- Helps reduce viral load effectively
- Supports immune system function
- Manufactured under strict quality standards
How It Helps
- Controls HIV replication in the body
- Improves immune system strength
- Reduces risk of HIV-related complications
- Supports long-term HIV treatment plans

Reviews
There are no reviews yet.